Stay updated on Safety of Tarlatamab in Adults With SCLC Clinical Trial
Sign up to get notified when there's something new on the Safety of Tarlatamab in Adults With SCLC Clinical Trial page.

Latest updates to the Safety of Tarlatamab in Adults With SCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check37 days agoChange DetectedThe date for an event has been updated from December 13, 2024, to February 14, 2025.SummaryDifference0.9%
- Check44 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check51 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
- Check66 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check73 days agoChange DetectedThe type of intervention has been updated from v2.13.3 to v2.14.0.SummaryDifference1.0%
Stay in the know with updates to Safety of Tarlatamab in Adults With SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Tarlatamab in Adults With SCLC Clinical Trial page.